Development and validation of the Unified Multiple System Atrophy Rating Scale (UMSARS)

Movement Disorders

Volumn 19, Issue 12, 2004, Pages 1391-1402

  Wenning, Gregor K ^a   Tison, François ^b   Seppi, Klaus ^a   Sampiao, Cristina ^c   Diem, Anja ^a   Yekhlef, Farid ^b   Ghorayeb, Imad ^b   Ory, Fabienne ^d   Galitzky, Monique ^d   Scaravilli, Tommaso ^e   Bozi, Maria ^e   Colosimo, Carlo ^f   Gilman, Sid ^g   Shults, Clifford W ^h   Quinn, Niall P ^e   Rascol, Olivier ^d   Poewe, Werner ^a   Dupont, Erik ⁱ   Ostergaard, Karen ⁱ   Tolosa, Eduardo ⁱ   Klockgether, Thomas ⁱ   Dodel, Richard ⁱ   Abele, Michael ⁱ   Pollak, Pierre ⁱ   Geser, Felix ⁱ   Stamfer, Michaela ⁱ   Deuschl, Günther ⁱ   Daniels, Christine ⁱ   Coelho, Miguel ⁱ   Pirtosek, Zvezdan ⁱ   Brooks, David J ⁱ   Fowler, Claire ⁱ   Lees, Andrew ⁱ   Mathias, Christopher J ⁱ   Revesz, Tamas ⁱ   Gerhard, Alexander ⁱ   Holton, Janice ⁱ   Schrag, Anette ⁱ   Wood, Nick ⁱ   Lindvall, Olle ⁱ   Widner, Håkan ⁱ   Grabowski, Martin ⁱ   Nilsson, Christer F ⁱ   Oertel, Wolfgang ⁱ   Eggert, Karla Maria ⁱ   Schimke, Nicole ⁱ   Albanese, Alberto ⁱ   del Sorbo, Francesco ⁱ   Barone, Paolo ⁱ   Carella, Francesco ⁱ   Djaljetti, Ruth ⁱ   Meco, Giuseppe ⁱ   Berciano, Jose ⁱ   Gonzalez Mandly, Andres ⁱ   Giladi, Nir ⁱ   Gurevich, Tanya ⁱ   Gasser, Thomas ⁱ   Kamm, Christoph ⁱ   Aquilonius, Sten Magnus ⁱ   Bergquist, Jonas ⁱ   more..

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b HAUT LÉVÊQUE HOSPITAL   (France)

^c HOSPITAL DE SANTA MARIA   (Portugal)

^d UNIVERSITÉ DE TOULOUSE   (France)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

^f SAPIENZA UNIVERSITY OF ROME   (Italy)

^g UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ NONE

Author keywords

Internal consistency; Interrater Reliability; Unified Multiple System Atrophy Rating Scale; Validation

Indexed keywords

ADULT; AGED; ANAMNESIS; ARTICLE; AUTONOMIC NERVOUS SYSTEM FUNCTION; CLINICAL ARTICLE; CLINICAL EXAMINATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISABILITY; DISEASE SEVERITY; FEMALE; HUMAN; MALE; MOTOR PERFORMANCE; MULTICENTER STUDY; OBSERVER VARIATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RATING SCALE; RELIABILITY; SCORING SYSTEM; SHY DRAGER SYNDROME; TIME; UNIFIED MULTIPLE SYSTEM ATROPHY RATING SCALE; VALIDATION PROCESS;

ACTIVITIES OF DAILY LIVING; AGE OF ONSET; AUTONOMIC NERVOUS SYSTEM; CEREBELLAR ATAXIA; DISABILITY EVALUATION; FEMALE; HUMANS; HYPOTENSION, ORTHOSTATIC; IMPOTENCE; MALE; MULTIPLE SYSTEM ATROPHY; OBSERVER VARIATION; PARKINSONIAN DISORDERS; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; SPEECH DISORDERS; URINARY INCONTINENCE; URINARY RETENTION;

EID: 19944428639     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.20255     Document Type: Article

References (31)

1. Gilman S, Low P, Quinn N, et al. Consensus statement on the diagnosis of multiple system atrophy. Clin Auton Res 1998;8:359-362.
2. Wenning GK, Ben Shlomo Y, Magalhaes M, et al. Clinical features and natural history of multiple system atrophy. An analysis of 100 cases. Brain 1994;117(Pt 4):835-845.
3. Wenning GK, Colosimo C, Geser F, Poewe W. Recent advances in multiple system atrophy. Lancet Neurology 2004;3:93-103.
4. Burn DJ, Jaros E. Multiple system atrophy: cellular and molecular pathology. Mol Pathol 2001;54:419-426.
5. Fahn S, Elton R, members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden C, Calne D, editors. Recent developments in Parkinson's disease. Vol. 2. New York: MacMillan Healthcare Information; 1987. p 153-163.
6. Trouillas P, Takayanagi T, Hallett M, et al. International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome. The Ataxia Neuropharmacology Committee of the World Federation of Neurology. J Neurol Sci 1997;145:205-211.
7. Schwab R, England A. Projection technique for evaluating surgery in Parkinson's disease. In: Gillingham F, Donaldson I, editors. Third symposium on Parkinson's disease. Edinburgh: Livingstone; 1969. p 152-175.
8. Suarez GA, Opfer-Gehrking TL, Offord KP, et al. The Autonomic Symptom Profile: a new instrument to assess autonomic symptoms. Neurology 1999;52:523-528.
9. Tison F, Yekhlef F, Balestre E, et al. Application of the International Cooperative Ataxia Scale rating in multiple system atrophy. Mov Disord 2002;17:1248-1254.
10. Tison F, Yekhlef F, Chrysostome V, et al. Parkinsonism in multiple system atrophy: natural history, severity (UPDRS-III), and disability assessment compared with Parkinson's disease. Mov Disord 2002;17:701-709.
11. Osaki Y, Wenning GK, Daniel SE, et al. Do published criteria improve clinical diagnostic accuracy in multiple system atrophy? Neurology 2002;59:1486-1491.
12. Defer GL, Widner H, Marie RK et al. Core assessment program for surgical interventional therapies in Parkinson's disease (CAP-SIT-PD). Mov Disord 1999;14:572-584.
13. Armitage P, Colton T. Crohnbach's alpha. Encyclopedia of biostatistics. 2nd ed. New York: John Wiley and Sons; 1998.
14. Cohen J. A coefficient of agreement for internal scales. Educ Psychol Meas 1960;20:37-46.
15. Fleiss J. Statistical models for rates and proportions. 2nd ed. New York: John Wiley and Sons; 1981.
16. Agresti A. Kappa weighted. Categorical data analysis. New York: John Wiley and Sons; 1990.
17. Schouten H. Nominal scale agreement among observers. Psychometrica 1986;51:453-466.
18. de Vet HC, Knipschild PG, Schouten HJ, et al. Interobserver variation in histopathological grading of cervical dysplasia. J Clin Epidemiol 1990;43:1395-1398.
19. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159-174.
20. Shrout P, Fleiss J. Intraclass correlations: uses in assessing rater reliability. Psychol Bull 1979;86:420-428.
21. Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. New Jersey: Lawrence Erlbaum Associates; 1988.
22. Colosimo C, Merello M, Pontieri F. Amantadine in parkinsonian patients unresponsive to levodopa: a pilot study. J Neurol 1996;243:422-425.
23. Fetoni V, Genitrini S, Monza D, et al. Variations in axial, proximal and distal motor response to L-dopa in multisystem atrophy and Parkinson's disease. Clin Neuropharmacol 1997;20:239-244.
24. Hughes A, Colosimo C, Kleedorfer B, et al. The dopaminergic response in multiple system atrophy. J Neurol Neurosurg Psychiatry 1992;55:1009-1013.
25. Martinez-Martin P, Gil-Nagel A, Gracia LM, et al. Unified Parkinson's Disease Rating Scale characteristics and structure. The Cooperative Multicentric Group. Mov Disord 1994;9:76-83.
26. Wenning G, Seppi K, Poewe W, et al. Differential association of orthostatic hypotension with the cerebellar versus parkinsonian presentation of multiple system atrophy. Neurology 2001;56:444.
27. Pirker W, Djamshidian S, Asenbaum S, et al. Progression of dopaminergic degeneration in Parkinson's disease and atypical parkinsonism: a longitudinal beta-CIT SPECT study. Mov Disord 2002;17:45-53.
28. Brucke T, Wenger S, Asenbaum S, et al. Dopamine D2 receptor imaging and measurement with SPECT. Adv Neurol 1993;60:494-500.
29. Schulz JB, Klockgether T, Petersen D, et al. Multiple system atrophy: natural history, MRI morphology, and dopamine receptor imaging with 123IBZM-SPECT. J Neurol Neurosurg Psychiatry 1994;57:1047-1056.
30. Schocke MF, Seppi K, Esterhammer R, et al. Diffusion-weighted MRI differentiates the Parkinson variant of multiple system atrophy from PD. Neurology 2002;58:575-580.
31. Seppi K, Schocke MF, Esterhammer R, et al. Diffusion-weighted imaging discriminates progressive supranuclear palsy from PD, but not from the Parkinson variant of multiple system atrophy. Neurology 2003;60:922-927.